A last-minute solution to the unresolved EU MRA issue is unlikely, so local manufacturers must prepare for Switzerland to be a “third country” to the EU after the MDR comes fully into force.
The EU and Switzerland are likely to see import and export problems arising from their ongoing political rift, including from the unresolved mutual recognition agreement (MRA) covering medical devices.
Switzerland has implemented the EU Medical Device Regulation, and on 26 May, its version, the Medizinprodukteverordnung (MepV), will come into force locally. But free cross border EU trade in medical...
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Its move comes as the Swiss recognize the need to ensure adequate supplies on medical devices in its country.
The medtech sector in the UK, Switzerland, and Germany face a challenging 2025, heads of national trade groups say. Competition and access to innovation remain key concerns across the board, with collaboration with the EU and US planned in Switzerland while Germany focuses on approaching elections.
Medtechs will be indirectly affected by a new law in Switzerland that unifies the amount of funding allocated to inpatient and ambulatory care.
